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Introduction
            The rate of implantable cardioverter defibrillator (ICD) implantation has gone up as 
primary   and   secondary   prevention   trials   have   relatively   consistently   shown   significant 
improvement in mortality and morbidity. Most patients with ICDs are followed routinely at 
intervals ranging from 3 to 6 months. Many patients require additional non-scheduled visits to 
investigate symptoms that may or may not relate to their cardiac disease or device. Appropriate 
and inappropriate therapies of implantable cardioverter defibrillators have a major impact on 
morbidity and quality of life in ICD recipients. Remote monitoring systems can substitute for 
routine follow-up visits and/ or deliver continuous diagnostic and device status information. 
Remote monitoring of ICDs can decrease the need for many patient visits and, thereby, probably 
reduce   expense.                                                              
Remote   Monitoring                                                              
            In the early 1970s, the concept of trans telephonic monitoring (TTM) was introduced to 
monitor the longevity of pacemakers1. This modality was identified as a useful method for 
tracking the basic function of pacemaker systems; particularly in the early era of pacemaker 
development when both lead and pulse generator longevities were unpredictable. In the late 
1970s and 1980s, the usefulness of TTM as a diagnostic tool expanded to other problems 
including   sensing,   capture,   lead   malfunction,   and   arrhythmias.   As   the   sophistication   of 
pacemakers increased,   the modes of follow up also inevitably changed. Most pacemaker 
manufacturers   now   have   systems   in   place   that   facilitate   remote   pacemaker   follow-up. 
Transmissions can be made totally trans-telephonically or, more recently, by using web-based 
networks. Implanted devices can be interrogated by using easy-to-use equipment in patients' 
homes (or elsewhere) that communicates stored and real-time information trans-telephonically to 
a secure server where the data are available to the pacemaker/heart rhythm professional.
               Just as for pacemakers, there are currently several systems either available or in 
development for the remote interrogation and monitoring of ICDs. Each system can only be used 
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with devices manufactured by the same company. Cardiomessenger & Home Monitoring from 
Biotronik uses diagnostic data transmitted from pacemakers, ICDs and heart failure devices to a 
mobile phone-like unit, then, in turn via cellular phone network, to a secure, remote monitoring 
center, and then further forwarded on to patients' clinical teams. Data is generated and 
transmitted at set times, following an event, or with patient-triggering. Similar in concept, 
CareLink from Medtronic, Housecall Plus from St. Jude Medical, and Latitude from Boston 
Scientific/Guidant   are   remote   monitoring   systems   that   use   standard   telephone   lines   to 
communicate with clinicians and/or secure computer servers which can be accessed by 
clinicians. Depending on the system, comprehensive device information including electrograms 
can be collected from the implanted device and transmitted and stored for clinician access and 
use.
Usefulness
            By diminishing the frequency of clinic visits, remote monitoring may reduce health care 
costs and patients' inconvenience. Diagnostic data from devices such as the numbers of aborted 
and delivered ICD therapies are an indicator of the total incidence of tachyarrhythmia. 
Frequently   recurring   episodes   of   ventricular   tachyarrhythmias   in   patients   may   indicate 
increasing instability and progression of cardiac disease2. Inappropriate ICD therapy, typically 
related to sinus tachycardia or other superventricular tachycardia can be elucidated remotely as 
well as in clinic3.  In one study, 59 patients completed 119 transmissions. Clinician review of 
data transmissions revealed several clinically significant findings, including silent AF discovery, 
assessment of antiarrhythmic drug efficacy in a previously diagnosed AF patient, previously 
unobserved atrial undersensing, and ventricular tachycardia. Clinicians were satisfied with the 
performance of the network and the quality of the web-accessed data, and found it comparable to 
an in-office device interrogation4.  In another prospective evaluation, 124 patients with single 
chamber ICDs were monitored by remote interrogation and monitoring for a total of 570 
transmissions.  The investigators demonstrated a high degree of patient satisfaction with the 
convenience and ease of use of remote ICD monitoring5.   Intracardiac electrograms (IEGMs) 
stored in the ICD can be essential for differentiating appropriate and inappropriate ICD 
therapies. High quality IEGMs are increasingly available with implanted devices and the remote 
monitoring   systems.   Validation   of   adequacy   of   remotely   acquired   IEGMs   is   under 
study6                                 
            Remote monitoring can be especially useful for monitoring patients with CRT-D devices. 
A prospective, longitudinal, multicenter home monitoring trial was conducted in 123 patients 
with clinical indications for CRT. In a mean follow-up period of 3 months, 11 unplanned re-
hospitalizations   for   cardiovascular   causes   and   9   deaths   occurred.   In   70%   of   the   re-
hospitalization events, the retrospective analysis of remotely acquired data revealed an increase 
in mean heart rate at rest and in mean heart rate over 24 h within 7 days preceding 
hospitalization. These interim findings suggest that remotely acquired data may predict events 
leading to hospitalization and encourage further research7. Other implantable devices using 
transthoracic impedance sensing in ICDs, and RV pressure parameter monitoring have been used 
with remote monitoring to assist in caring for patients with heart failure.                   
                                                                                                                                                            
            An important and untapped potential utility for remotely monitored devices in which data 
is collected in large databases involves the capacity to predict device performance problems. 
Cost Effectiveness  
                                                             
               In a cost effectiveness study conducted among 502 patients, costs of conventional 
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follow-up of ICDs were calculated without and compared with the expected cost of follow up 
with remote monitoring. It was concluded that the remote monitoring may considerably reduce 
the overall costs of ICD follow up by saving on transportation cost, particularly when the 
distance  between home and  medical facility  is >100 km8. Patient satisfaction  with  the 
convenience and reliability of the remote monitoring system ranged from 93 to 97% in SF-36 
surveys9
Conclusion
            Remote interrogation provides frequent, convenient, safe and comprehensive monitoring 
of ICDs. Device and patient related problems can be reliably detected and reduce the frequency 
of outpatient visits. Patients are highly satisfied with the convenience and ease of use of the 
systems. Surveillance of device performance is a potentially important future capability. In the 
future an exponential growth in implementation of remote monitoring is likely to occur in the 
field of implanted devices including ICDs, pacemakers, and implantable disease monitors.
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